|
Volumn 25, Issue 1, 2007, Pages 42-46
|
Liver transplantation
|
Author keywords
immunosuppression; liver transplantation
|
Indexed keywords
ANTIMETABOLITE;
AZATHIOPRINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CALCINEURIN INHIBITOR;
CALCIUM;
CALCIUM CHANNEL BLOCKING AGENT;
CORTICOSTEROID;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ORAL ANTIDIABETIC AGENT;
TACROLIMUS;
VITAMIN D;
ACUTE GRAFT REJECTION;
ANEMIA;
ARTIFICIAL LIVER;
CARDIOVASCULAR DISEASE;
CHRONIC GRAFT REJECTION;
CORTICOSTEROID INDUCED OSTEOPOROSIS;
DIABETES MELLITUS;
DONOR SELECTION;
GRAFT SURVIVAL;
HEMODIALYSIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
LEUKOPENIA;
LIVER DISEASE;
LIVER GRAFT;
LIVER TRANSPLANTATION;
LIVING DONOR;
LOW DRUG DOSE;
NEUROLOGIC DISEASE;
OBESITY;
ORGAN DONOR;
OSTEOPOROSIS;
PATIENT REFERRAL;
PATIENT SELECTION;
PORTAL VEIN THROMBOSIS;
POSTOPERATIVE CARE;
POSTOPERATIVE INFECTION;
POSTOPERATIVE THROMBOSIS;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RETRANSPLANTATION;
REVASCULARIZATION;
REVIEW;
SURGICAL TECHNIQUE;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
|
EID: 33846015061
PISSN: 02639319
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpsur.2006.11.008 Document Type: Review |
Times cited : (3)
|
References (10)
|